Few & Far Between: Conversations from the Front Lines of Drug Development

36 Episodes

1. Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech

   Published: 9/3/2025
2. Episode 58: Jerry McLaughlin, CEO and Board Member at Life Biosciences

   Published: 8/14/2025
3. Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation

   Published: 7/22/2025
4. Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

   Published: 7/15/2025
5. Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®

   Published: 7/9/2025
6. Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

   Published: 5/28/2025
7. Episode 53: Frank David, Founder and Managing Director, Pharmagellan

   Published: 4/29/2025
8. Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI

   Published: 4/23/2025
9. Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

   Published: 4/3/2025
10. Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova

    Published: 3/18/2025
11. Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health

    Published: 2/27/2025
12. Episode 48: John Celebi, President and CEO, Sensei Bio

    Published: 2/18/2025
13. Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures

    Published: 1/15/2025
14. Episode 47 - Marc Lajoie, CEO at Outpace Bio

    Published: 12/31/2024
15. Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

    Published: 12/12/2024
16. Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics

    Published: 10/23/2024
17. Episode 43: Isaac Stoner, Co-founder and CEO at Octagon Therapeutics

    Published: 9/12/2024
18. Episode 42: Diana Azzam, PhD, Assistant Professor at Florida International University, Co-Founder at First Ascent Biomedical

    Published: 7/16/2024
19. Episode 41: Craig Serra, Head of Clinical Research Scientific and Technical Engagement, Flatiron Health

    Published: 5/23/2024
20. Episode 40: Professor Justin Stebbing, Editor-in-Chief, Oncogene journal

    Published: 4/25/2024